Delivery Order SPE2DB24D3013-SPE2DB24FFGFY

Award Date 7/16/24
Potential Completion Date 7/17/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of QULIPTA 30 MG TABLET 30S. The award, valued at $1,237.79, has an ultimate completion date of September 3, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 and running through December 2025. The IDC enables the DLA to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, for the supply of QULIPTA 60 MG TABLET 30S. The award, valued at $7,525.35, is a firm fixed-price contract with a completion date of September 10, 2024. The contract is not set aside for any specific business type. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of QULIPTA 60 MG TABLET 30S. The order has a firm fixed price of $1,638.21 and a completion date of September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of QULIPTA 60 MG TABLET 30S. The $11,274.39 firm fixed-price delivery order was awarded on September 16, 2024, with a completion date of September 17, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,697.75 firm-fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,188.82 firm fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of QULIPTA 30 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $2,841.64 and a performance period ending on March 12, 2025. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of the pharmaceutical product QULIPTA 30 MG TABLET 30S. The contract, valued at $2,749.16, has a firm fixed price and an ultimate completion date of October 23, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside contract. The contract is associated with a...
This is a $7,110.10 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of QULIPTA 60 MG TABLET 30S. The award does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,495.11, is for the delivery of QULIPTA 60 MG TABLET 30S, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 1, 2025. This award is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFGFY
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of QULIPTA 60 MG TABLET 30S. The $2,131.38 firm-fixed-price contract has a completion date of July 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a wide range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/15/24, 9:29 PM